Nocardia species. The recovery of the organism from the BacT/Alert broth confirmed the 1 presence of nocardiae at this site. 2 Antimicrobial treatment with amikacin, imipenem and cotrimoxazole was restarted. No 3 other localization of the disease was found at this time. 4
One month later, amikacin was stopped despite a temperature above 39°C and an 5 increased CRP above 200 mg/L following each haemodialysis session. Amoxicillin (2 g 6 three times daily by the oral route) was started. 7
In October 2001, a new CT scan revealed a voluminous psoas abscess [ Figure 3 ]. 8
It was drained surgically under tomographic guidance. 9
A Gram stain of the evacuated pus showed a branched-positive rod, and a modified acid-10 fast stain was positive for organisms morphologically consistent with Nocardia species. 11
Bacteriologic culture grew a Nocardia species. 12 The lumbar pain improved, the patient became afebrile and the CRP decreased to 13 30 mg/L two weeks after drainage. Imipenem was switched to erythromycin (1 g three 14 times daily by the oral route) because of adverse side effects (a seizure). Again, the CRP 15 began to increase, and another CT scan was performed. The abscess had increased in 16
size, so open surgery was performed to drain the psoas abscess. After the surgical 17 procedure and a one-year treatment with oral erythromycin and amoxicillin, the patient's 18 clinical condition had improved. 19
The Nocardia isolates were referred to the "Nocardiosis French Observatory" where 20 they were subsequently identified as N. nova by biochemical testing including the positif 21 2-week arylsulfatase assay, the negative decomposition of casein, xanthine, tyrosine, and 22
hypoxanthine. Accurate species identification was determined by sequencing of the 5'end 23 606-base-pair fragment of the 16S rRNA gene and concluded to N. nova sensu stricto. 1
The gene was amplified as previously described (15) with primers Noc1 (5′-2 GCTTAACACATGCAAGTCG-3′) (position 46 to 64, Escherichia coli numbering 3 system) and Noc2 (5′-GAATTCCAGTCTCCCCTG-3′) (position 663 to 680, E. coli 4 numbering system) and the sequencing gene was based on the search of the 5 phylogenically closest known species inferred from database of "Nocardiosis French 6
Observatory". This database included 16S rRNA sequences from reference strains of all 7 validated nocardial species. The database comparison, using Bibi software (7), generated 8 a list of the closest matches with pairwise distance scores indicating the percentage 9 difference between the unknown sequence and the database sequences. The three strains 10 which were recovered from our patient were formed a phylogenetical individualized 11 cluster with N. nova ATCC 33726T (data not shown) and showed 100 % similarity to the 12 type strain. 13
Comparison of the relapse isolates with the agent from the primary pulmonary infection 14 was performed by random amplified polymorphic DNA (RAPD), using DKU49 (5'-15 CCGCCGACCGAG-3') primer as previously described (13 The nocardiae are infrequently recognized to cause clinical disease in normal 1 patients, but they are more frequently diagnosed causing disease in immunocompromised 2 patients. The predisposing factors are long term corticosteroid therapy, chronic lung 3 disease, hematologic and other malignancies, and organ transplantation. Renal transplant 4 recipients are a sub-group of immunocompromised patients for whom Nocardia is an 5 important cause of morbidity and mortality and the prevalence of nocardiosis has been 6 reported to be as high as 5% (9, 22). Risk factors for nocardiosis in renal transplant 7 recipients include multiple early rejection, intensive immunosuppressive therapy, and 8 granulocytopenia (1) . Recently, mycophenolate compounds, which block the 9 proliferation of T and B cells, inhibit antibody formation and prevent the generation of 10 cytotoxic T cells, have been implicated as predisposing factors for nocardial infection 11 (11, 14) . Our patient had all of these predisposing factors. 12
Pulmonary nocardiosis is the primary clinical finding which may be either self-13 limited or subclinical. It may progress to an acute, subacute, or chronic process 14 mimicking tuberculous, mycotic infections or a neoplasm (10). Once blood-borne, the 15 organisms can invade other anatomic locations, with the frequency of disseminated 16 disease ranging between 28% and 56% (17, 19). The most common sites for 17 dissemination are the central nervous system, skin and subcutaneous tissues, eyes 18 (especially the retina), kidneys, joints and the heart (12). Osteomyelitis due to nocardiae 19 is uncommon. Only 12 cases of Nocardia osteomyelitis of the spine have been published 20 over the past 40 years and four of them were lumbar sites (8). 21
The clinical diagnosis of nocardiosis is difficult. Signs, symptoms, and radiology are not 22 pathognomonic. However due to the nature and gravity of nocardiosis, rapid and precise 23 identification of these agents are important. In routine clinical laboratory, the evaluation 1 of appropriate specimens by smear and culture remains the principal method of 2 diagnosis. Phenotypic characteristics are often used in conjunction with antimicrobial 3 susceptibility patterns to help identification some nocardial isolates (4, 5, 6, 18, 21) . N. 4 nova complex has a distinct antimicrobial susceptibility pattern; they are susceptible or 5 moderately susceptible to both amoxicillin and erythromycin and resistant to both 6 amoxicillin-clavulanic-acid and tobramycin (5, 6, 18, 20) . Although, phenotypic methods 7 and susceptibility patterns are used for identification, but they are not reliable as 8 definitive identification methods. Gene sequencing provides a more reliable 9 identification and, the 16S rRNA gene sequence has become the new gold standard (3). 10
Accurate strain identification is essential for defining the spectrum of disease caused by 11 each species, predicting antimicrobial susceptibility, and for general comparisons of 12 clinical isolates for epidemiological reasons. 13
Nocardiosis is also often difficult to treat and can be guided by susceptibility 14 testing. Early and prolonged treatment with a combination of antibiotics is necessary in 15 order to avoid either recurrence of infection, or metastatic spread, or drug resistance. The duration of therapy for nocardiosis is uncertain, but it should be protracted because 22 of the high incidence of relapse following shorter courses of therapy (2). 23
The spondylodiscitis and psoas abscess reported above followed dissemination 1 from the lung, which was the primary site of nocardial infection. The bacteriologic etiology of this spondylodiscitis was not obtained by direct culture of 9 the aspirate of the affected vertebra onto blood agar and chocolate plates may be due to 10 the very low level of bacteria at this site. Nocardia species was detected at this site by 11 using the BacT/Alert system and when the sample was subcultured late (after 4 weeks 12 incubation) onto blood agar medium. So, we recommend the processing of the such 13 sample through the Bact/Alert system or similar system for increase the growth 14 sensitivity of nocardiae. 15
Once the diagnosis of pulmonary nocardiosis was made, the patient described 16 above had received three months of antimicrobial therapy included imipenem, amikacin 17 and cotrimoxazole for pulmonary nocardiosis. Obviously this duration was insufficient, 18 explaining the spread of the disease eight months after the discontinuation of the therapy. 
